Thyrocare Technologies Q4 Results
- BSE: 539871
- NSE: THYROCARE
- ISIN: INE594H01019
- Sector: Healthcare Facilities
BSE
1,063.30
-11.90 (-1.11%)
-11.90 (-1.11%)Volume17.48 K
Updated: Tue 8 Jul, 2025 | 15:28:42
NSE
1,055.50-16.60 (-1.55%)
-16.60 (-1.55%)Volume1.34 L
Updated: Tue 8 Jul, 2025 | 15:30:02
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹187.16 Cr.(21.34%)
- Operating Profit₹43.93 Cr.(102.35%)
- Profit After Tax₹21.70 Cr.(22.05%)
- Operating Margin23.47%(66.77%)
Note: Comparison is on YoY basis
Quarterly - Thyrocare Technologies Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 143.23 | 141.25 | 1.40% | 132.54 | 8.07% |
| Depreciation/ Amortization | 13.77 | 17.06 | -19.28% | 13.06 | 5.44% |
| Operating Income | 43.93 | 24.67 | 78.07% | 21.71 | 102.35% |
| Net Income | 21.70 | 19.11 | 13.55% | 17.78 | 22.05% |
| Other Operating Expenses Total | 46.52 | 43.94 | 5.87% | 37.51 | 24.02% |
| Net Income Before Taxes | 47.19 | 27.92 | 69.02% | 22.91 | 105.98% |
| Total Revenue | 187.16 | 165.92 | 12.80% | 154.25 | 21.34% |
| Selling/ General/ Admin Expenses Total | 33.47 | 35.09 | -4.62% | 35.40 | -5.45% |
| Diluted Normalized EPS | 4.16 | 3.56 | 16.85% | 3.61 | 15.34% |